APA (7th ed.) Citation

Å, F., D, G., J, A., KG, W., S, B., & N, M. (2016). Strong synergy with APR-246 and DNA-damaging drugs in primary cancer cells from patients with TP53 mutant High-Grade Serous ovarian cancer. Journal of ovarian research, 9(1), 27. https://doi.org/10.1186/s13048-016-0239-6

Chicago Style (17th ed.) Citation

Å, Fransson, Glaessgen D, Alfredsson J, Wiman KG, Bajalica-Lagercrantz S, and Mohell N. "Strong Synergy with APR-246 and DNA-damaging Drugs in Primary Cancer Cells from Patients with TP53 Mutant High-Grade Serous Ovarian Cancer." Journal of Ovarian Research 9, no. 1 (2016): 27. https://doi.org/10.1186/s13048-016-0239-6.

MLA (9th ed.) Citation

Å, Fransson, et al. "Strong Synergy with APR-246 and DNA-damaging Drugs in Primary Cancer Cells from Patients with TP53 Mutant High-Grade Serous Ovarian Cancer." Journal of Ovarian Research, vol. 9, no. 1, 2016, p. 27, https://doi.org/10.1186/s13048-016-0239-6.